[1] [1] SCHRODER K, TSCHOPP J. The inflammasomes［J］. Cell, 2010, 140(6): 821-832.

[2] [2] BROZ P, DIXIT V M. Inflammasomes: mechanism of assembly, regulation and signalling［J］. Nature Reviews Immunology, 2016, 16(7): 407-420.

[3] [3] BROZ P, VON MOLTKE J, JONES J W, et al. Differential requirement for Caspase-1 autoproteolysis in pathogen-induced cell death and cytokine processing［J］. Cell Host Microbe, 2010, 8(6): 471-83.

[4] [4] SWANSON K V, DENG M, TING J P. The NLRP3 inflammasome: molecular activation and regulation to therapeutics［J］. Nature Reviews Immunology, 2019, 19(8): 477-489.

[5] [5] GUO H, CALLAWAY J B, TING J P. Inflammasomes: mechanism of action, role in disease, and therapeutics［J］. Nature Medicine, 2015, 21(7): 677-687.

[6] [6] BROZ P, PELEGRíN P, SHAO F. The gasdermins, a protein family executing cell death and inflammation［J］. Nature Reviews Immunology, 2020, 20(3): 143-157.

[7] [7] STROWIG T, HENAO-MEJIA J, ELINAV E, et al. Inflammasomes in health and disease［J］. Nature, 2012, 481(7381): 278-286.

[8] [8] DAVIS B K, WEN H, TING J P. The inflammasome NLRs in immunity, inflammation, and associated diseases［J］. Annual Review of Immunology,?2011, 29: 707-735.

[9] [9] WEN H, TING J P, O’NEILL L A. A role for the NLRP3 inflammasome in metabolic diseases―did Warburg miss inflammation?［J］. Nature Immunology,?2012, 13(4): 352-357.

[10] [10] MANGAN M S J, OLHAVA E J, ROUSH W R, et al. Targeting the NLRP3 inflammasome in inflammatory diseases［J］. Nature Reviews Drug Discovery, 2018, 17(8): 588-606.

[11] [11] CHEN S, CHI Z, WANG D. Reconstitution system of NLRP3 inflammasome in HEK293T cells［J］. Methods in Molecular Biology, 2022, 2459: 79-84.

[12] [12] SHI H, MURRAY A, BEUTLER B. Reconstruction of the mouse inflammasome system in HEK293T cells［J］. Bio-protocol, 2016, 6(21): e1986.

[13] [13] SONG N, LIU Z S, XUE W, et al. NLRP3 phosphorylation is an essential priming event for inflammasome activation［J］. Molecular Cell,?2017, 68(1): 185-197.e6.

[14] [14] HUANG L, LUO R, LI J, et al. β-catenin promotes NLRP3 inflammasome activation via increasing the association between NLRP3 and ASC［J］. Molecular Immunology,?2020, 121: 186-194.

[15] [15] GUO C, CHI Z, JIANG D, et al. Cholesterol homeostatic regulator SCAP-SREBP2 integrates NLRP3 inflammasome activation and cholesterol biosynthetic signaling in macrophages［J］. Immunity, 2018, 49(5): 842-856.e7.

[16] [16] WANG D, ZHANG Y, XU X, et al. YAP promotes the activation of NLRP3 inflammasome via blocking K27-linked polyubiquitination of NLRP3［J］. Nature Communications,?2021, 12(1): 2674.

[17] [17] VAN DE VEERDONK F L, NETEA M G. New insights in the immunobiology of IL-1 family members［J］. Frontiers in Immunology, 2013, 4: 167.

[19] [19] THOMAS P, SMART T G. HEK293 cell line: a vehicle for the expression of recombinant proteins［J］. Journal of Pharmacological and Toxicological Methods, 2005, 51(3): 187-200.

[20] [20] PULIX M, LUKASHCHUK V, SMITH D C, et al. Molecular characterization of HEK293 cells as emerging versatile cell factories［J］. Current Opinion in Biotechnology, 2021, 71: 18-24.

[21] [21] YU J W, WU J, ZHANG Z, et al. Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization［J］. Cell Death and Differentiation, 2006, 13(2): 236-249.